424 related articles for article (PubMed ID: 27773462)
1. NF-κB signaling pathway and its potential as a target for therapy in lymphoid neoplasms.
Yu L; Li L; Medeiros LJ; Young KH
Blood Rev; 2017 Mar; 31(2):77-92. PubMed ID: 27773462
[TBL] [Abstract][Full Text] [Related]
2. Molecularly-targeted Strategy and NF-κB in lymphoid malignancies.
Horie R
J Clin Exp Hematop; 2013; 53(3):185-95. PubMed ID: 24369220
[TBL] [Abstract][Full Text] [Related]
3. Pathogenetic importance and therapeutic implications of NF-κB in lymphoid malignancies.
Lim KH; Yang Y; Staudt LM
Immunol Rev; 2012 Mar; 246(1):359-78. PubMed ID: 22435566
[TBL] [Abstract][Full Text] [Related]
4. Targeting the NF-κB pathway in prostate cancer: a promising therapeutic approach?
Verzella D; Fischietti M; Capece D; Vecchiotti D; Del Vecchio F; Cicciarelli G; Mastroiaco V; Tessitore A; Alesse E; Zazzeroni F
Curr Drug Targets; 2016; 17(3):311-20. PubMed ID: 26343112
[TBL] [Abstract][Full Text] [Related]
5. The Role of PI3K Inhibition in Lymphoid Malignancies.
von Keudell G; Moskowitz AJ
Curr Hematol Malig Rep; 2019 Oct; 14(5):405-413. PubMed ID: 31359259
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of NF-κB deregulation in lymphoid malignancies.
Krappmann D; Vincendeau M
Semin Cancer Biol; 2016 Aug; 39():3-14. PubMed ID: 27262792
[TBL] [Abstract][Full Text] [Related]
7. The NF-kappaB signalling pathway: a therapeutic target in lymphoid malignancies?
Stoffel A
Expert Opin Ther Targets; 2005 Oct; 9(5):1045-61. PubMed ID: 16185157
[TBL] [Abstract][Full Text] [Related]
8. Targeting the NF-κB pathway in cancer therapy.
Erstad DJ; Cusack JC
Surg Oncol Clin N Am; 2013 Oct; 22(4):705-46. PubMed ID: 24012396
[TBL] [Abstract][Full Text] [Related]
9. Classic and Novel Signaling Pathways Involved in Cancer: Targeting the NF-κB and Syk Signaling Pathways.
Tang C; Zhu G
Curr Stem Cell Res Ther; 2019; 14(3):219-225. PubMed ID: 30033874
[TBL] [Abstract][Full Text] [Related]
10. Targeting Oncogenic Nuclear Factor Kappa B Signaling with Redox-Active Agents for Cancer Treatment.
Fouani L; Kovacevic Z; Richardson DR
Antioxid Redox Signal; 2019 Mar; 30(8):1096-1123. PubMed ID: 29161883
[TBL] [Abstract][Full Text] [Related]
11. NF-κB and the link between inflammation and cancer.
DiDonato JA; Mercurio F; Karin M
Immunol Rev; 2012 Mar; 246(1):379-400. PubMed ID: 22435567
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms and consequences of constitutive NF-κB activation in B-cell lymphoid malignancies.
Nagel D; Vincendeau M; Eitelhuber AC; Krappmann D
Oncogene; 2014 Dec; 33(50):5655-65. PubMed ID: 24469030
[TBL] [Abstract][Full Text] [Related]
13. Molecular Pathways: The Balance between Cancer and the Immune System Challenges the Therapeutic Specificity of Targeting Nuclear Factor-κB Signaling for Cancer Treatment.
Zeligs KP; Neuman MK; Annunziata CM
Clin Cancer Res; 2016 Sep; 22(17):4302-8. PubMed ID: 27422962
[TBL] [Abstract][Full Text] [Related]
14. The role of NF-kappaB in lymphoid malignancies.
Packham G
Br J Haematol; 2008 Oct; 143(1):3-15. PubMed ID: 18573107
[TBL] [Abstract][Full Text] [Related]
15. Molecular deregulation of signaling in lymphoid tumors.
Spina V; Martuscelli L; Rossi D
Eur J Haematol; 2015 Oct; 95(4):257-69. PubMed ID: 25881749
[TBL] [Abstract][Full Text] [Related]
16. The IKK/NF-kappaB activation pathway-a target for prevention and treatment of cancer.
Greten FR; Karin M
Cancer Lett; 2004 Apr; 206(2):193-9. PubMed ID: 15013524
[TBL] [Abstract][Full Text] [Related]
17. Wogonin as a targeted therapeutic agent for EBV (+) lymphoma cells involved in LMP1/NF-κB/miR-155/PU.1 pathway.
Wu X; Liu P; Zhang H; Li Y; Salmani JM; Wang F; Yang K; Fu R; Chen Z; Chen B
BMC Cancer; 2017 Feb; 17(1):147. PubMed ID: 28222771
[TBL] [Abstract][Full Text] [Related]
18. Oncogenic activation of NF-kappaB.
Staudt LM
Cold Spring Harb Perspect Biol; 2010 Jun; 2(6):a000109. PubMed ID: 20516126
[TBL] [Abstract][Full Text] [Related]
19. Pathogenic B-cell receptor signaling in lymphoid malignancies: New insights to improve treatment.
Young RM; Phelan JD; Wilson WH; Staudt LM
Immunol Rev; 2019 Sep; 291(1):190-213. PubMed ID: 31402495
[TBL] [Abstract][Full Text] [Related]
20. NF-κB activation in chronic lymphocytic leukemia: A point of convergence of external triggers and intrinsic lesions.
Mansouri L; Papakonstantinou N; Ntoufa S; Stamatopoulos K; Rosenquist R
Semin Cancer Biol; 2016 Aug; 39():40-8. PubMed ID: 27491692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
